Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.

Anaemia of chronic disease (ACD) is a common feature of active rheumatoid arthritis (RA). Inflammatory cytokines, particularly tumour necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1) and interleukin-6 (IL-6), are thought to contribute to the pathogenesis of ACD, possibly by inhibiting erythro...

Bibliografske podrobnosti
Main Authors:	Davis, D, Charles, P, Potter, A, Feldmann, M, Maini, R, Elliott, M
Format:	Journal article
Jezik:	English
Izdano:	1997

Podobne knjige/članki

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
od: Maini, R, et al.
Izdano: (1995)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
od: Brennan, F, et al.
Izdano: (1995)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1997)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
od: Elliott, M, et al.
Izdano: (1995)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
od: Elliott, M, et al.
Izdano: (1994)

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
od: Taylor, P, et al.
Izdano: (2000)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
od: Feldmann, M
Izdano: (1996)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
od: Williams, R, et al.
Izdano: (2000)

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
od: Maini, R, et al.
Izdano: (1994)

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
od: Buchan, G, et al.
Izdano: (1988)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
od: Elliott, M, et al.
Izdano: (1993)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
od: Paleolog, E, et al.
Izdano: (1996)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
od: Maini, R, et al.
Izdano: (1997)

TNFα blockade in rheumatoid arthritis: Rationale, clinical outcomes and mechanisms of action
od: Elliott, M, et al.
Izdano: (1995)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
od: Feldmann, M, et al.
Izdano: (1997)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1994)

Cytokine blockade in rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (2001)

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
od: Maini, R, et al.
Izdano: (1998)

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
od: Elliott, M, et al.
Izdano: (1994)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
od: Maini, R, et al.
Izdano: (1994)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
od: Elliot, M, et al.
Izdano: (2008)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
od: Maini, R, et al.
Izdano: (1999)

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
od: Chu, C, et al.
Izdano: (1991)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1995)

TNF alpha as a therapeutic target in rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1994)

Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells.
od: Zheng, R, et al.
Izdano: (1992)

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.
od: Haworth, C, et al.
Izdano: (1991)

Effects of treatment of rheumatoid arthritis patients with an antibody against tumour necrosis factor alpha on reticuloendothelial and intrapulmonary granulocyte traffic.
od: Taylor, P, et al.
Izdano: (1999)

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
od: Brennan, F, et al.
Izdano: (1997)

TNF alpha--a pivotal role in rheumatoid arthritis?
od: Brennan, F, et al.
Izdano: (1992)

Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply
od: Taylor, P, et al.
Izdano: (2001)

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
od: Paleolog, E, et al.
Izdano: (1998)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (2001)

Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
od: Mukhtyar, C, et al.
Izdano: (2005)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
od: Feldmann, M, et al.
Izdano: (2001)

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.
od: Deleuran, B, et al.
Izdano: (1992)

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
od: Ulfgren, A, et al.
Izdano: (2000)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
od: Maini, R, et al.
Izdano: (1993)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
od: Feldmann, M, et al.
Izdano: (2002)

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
od: Maini, R, et al.
Izdano: (1998)